Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Sep 30, 2020

Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the...


Sep 30, 2020

Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the...


Sep 30, 2020

Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's...


Sep 30, 2020

Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's...


Sep 23, 2020

Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium,...